Accordingly, In many experiments the co-expression of SMAD3 or SMAD4 (the important proteins in TGF-β signaling) or TGF-β with RUNX3 has been exploited to reinforce RUNX3 efficiency in inhibition of tumor growth (23). The gene discussed is TGFB1; the disease is neoplasm.